The Vancouver Prostate Centre's MyPOP (My Precision Oncology Program) is a recently launched clinical research program which strives to better deliver personalized therapeutics to patients with advanced or treatment-resistant cancer of the prostate, kidney or bladder.
The program is currently available only to patients of the VPC or BCCA who meet specific clinical trial criteria.
The program's objectives are to:
- Develop standardized procedures to enable routine linking of genomic sequencing data with clinical decision making,
- Integrate research and development of plasma DNA and RNA assays into clinical practice, and
- Integrate clinical information with novel model systems
A schematic overview of the program is below:
